Oscar Health, Inc. (OSCR) closed the most recent trading day at $33.47, moving -2.48% from the previous trading session. The stock fell short of the S&P 500, which registered a gain of 0.33% for the day. Elsewhere, the Dow gained 1.08%, while the tech-heavy Nasdaq added 0.08%.
Coming into today, shares of the company had gained 6.12% in the past month. In that same time, the Finance sector lost 3.99%, while the S&P 500 gained 1.41%.
The investment community will be paying close attention to the earnings performance of Oscar Health, Inc. in its upcoming release. The company is slated to reveal its earnings on November 5, 2026. The company is predicted to post an EPS of -$0.11, indicating a 79.25% growth compared to the equivalent quarter last year. Alongside, our most recent consensus estimate is anticipating revenue of $4.72 billion, indicating a 58.14% upward movement from the same quarter last year.
Regarding the entire year, the Zacks Consensus Estimates forecast earnings of $1.83 per share and revenue of $18.81 billion, indicating changes of +208.28% and +60.77%, respectively, compared to the previous year.
Investors might also notice recent changes to analyst estimates for Oscar Health, Inc. Such recent modifications usually signify the changing landscape of near-term business trends. Therefore, positive revisions in estimates convey analysts' confidence in the business performance and profit potential.
Research indicates that these estimate revisions are directly correlated with near-term share price momentum. To capitalize on this, we've crafted the Zacks Rank, a unique model that incorporates these estimate changes and offers a practical rating system.
The Zacks Rank system, running from #1 (Strong Buy) to #5 (Strong Sell), holds an admirable track record of superior performance, independently audited, with #1 stocks contributing an average annual return of +25% since 1988. Over the past month, there's been a 18.79% rise in the Zacks Consensus EPS estimate. Oscar Health, Inc. is currently a Zacks Rank #1 (Strong Buy).
With respect to valuation, Oscar Health, Inc. is currently being traded at a Forward P/E ratio of 18.72. This denotes a premium relative to the industry average Forward P/E of 10.07.
Also, we should mention that OSCR has a PEG ratio of 0.38. The PEG ratio is similar to the widely-used P/E ratio, but this metric also takes the company's expected earnings growth rate into account. Insurance - Multi line stocks are, on average, holding a PEG ratio of 0.94 based on yesterday's closing prices.
The Insurance - Multi line industry is part of the Finance sector. This industry, currently bearing a Zacks Industry Rank of 99, finds itself in the top 41% echelons of all 250+ industries.
The Zacks Industry Rank evaluates the power of our distinct industry groups by determining the average Zacks Rank of the individual stocks forming the groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.
Ensure to harness Zacks.com to stay updated with all these stock-shifting metrics, among others, in the next trading sessions.
Zacks' Research Chief Names "Stock Most Likely to Double"
Our team of experts has just released the 5 stocks with the greatest probability of gaining +100% or more in the coming months. Of those 5, Director of Research Sheraz Mian highlights the one stock set to climb highest.
This innovative software-as-a-service firm upped its user base +22% year over year. That rate is increasing and margins are expanding as AI efficiencies take effect. Of course, all our elite picks aren't winners, but this one could far surpass earlier Zacks' Stocks Set to Double like D-Wave Quantum, which shot up +680.1%.
Free: See Our Top Stock And 4 Runners UpWant the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
Oscar Health, Inc. (OSCR): Free Stock Analysis Report
This article originally published on Zacks Investment Research (zacks.com).